STOCK TITAN

Nantahala Capital discloses 3.61% Savara (SVRA) stake in amended 13G filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Savara Inc. (SVRA) received an amended Schedule 13G from Nantahala Capital Management and its principals, Wilmot B. Harkey and Daniel Mack, reporting their beneficial ownership in the company’s common stock. As of December 31, 2025, they may be deemed to beneficially own 7,344,783 shares, representing 3.61% of Savara’s outstanding common stock.

The filing shows they have no sole voting or dispositive power, but share voting and dispositive power over all reported shares through funds and accounts managed by Nantahala. The securities are stated to be held in the ordinary course of business and not for the purpose of changing or influencing control of Savara.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Nantahala Capital Management, LLC
Signature:/s/ Taki Vasilakis
Name/Title:Taki Vasilakis / Chief Compliance Officer
Date:02/13/2026
Wilmot B. Harkey
Signature:/s/ Wilmot B. Harkey
Name/Title:Wilmot B. Harkey
Date:02/13/2026
Daniel Mack
Signature:/s/ Daniel Mack
Name/Title:Daniel Mack
Date:02/13/2026

FAQ

What ownership stake in Savara Inc. (SVRA) is reported in this Schedule 13G/A?

The filing reports that Nantahala Capital Management and its principals may beneficially own 7,344,783 shares of Savara Inc. common stock, representing 3.61% of the outstanding shares as of December 31, 2025. This reflects a sub-5% institutional ownership position.

Who are the reporting persons in the Savara Inc. (SVRA) Schedule 13G/A?

The reporting persons are Nantahala Capital Management, LLC, and its managing members Wilmot B. Harkey and Daniel Mack. They report shared voting and dispositive power over the Savara shares held by funds and separately managed accounts under Nantahala’s control.

Does Nantahala seek to influence control of Savara Inc. (SVRA) with this stake?

The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Savara. It also notes the holdings are not in connection with any control-related transaction, other than limited nomination activities referenced in the certification.

What voting and dispositive powers are reported over Savara Inc. (SVRA) shares?

The Schedule 13G/A reports 0 shares with sole voting or dispositive power for each reporting person. They disclose 7,344,783 shares with shared voting and shared dispositive power, reflecting control through funds and accounts managed by Nantahala Capital Management.

Why is this Savara Inc. (SVRA) filing labeled as an amended Schedule 13G/A?

It is marked as Amendment No. 1 to a Schedule 13G, indicating a revision to previously reported beneficial ownership information. As of December 31, 2025, the reporting group’s stake is disclosed at 3.61%, which is described under Item 5 as ownership of 5 percent or less of the class.

What type of securities in Savara Inc. (SVRA) are covered by this Schedule 13G/A?

The filing covers Savara Inc.’s common stock, with a par value of $0.001 per share, identified by CUSIP 805111101. All reported ownership percentages and share amounts relate specifically to this class of Savara’s equity securities.
Savara Inc

NASDAQ:SVRA

SVRA Rankings

SVRA Latest News

SVRA Latest SEC Filings

SVRA Stock Data

1.14B
187.64M
5.38%
99.91%
9.07%
Biotechnology
Pharmaceutical Preparations
Link
United States
AUSTIN